Anti-IL6-receptor-alpha (tocilizumab) does not inhibit human monocyte-derived dendritic cell maturation or alloreactive T-cell responses. [electronic resource]
Producer: 20120103Description: 5340-3 p. digitalISSN:- 1528-0020
- Animals
- Antibodies, Monoclonal, Humanized -- pharmacology
- Cell Differentiation -- immunology
- Dendritic Cells -- cytology
- Graft vs Host Disease -- immunology
- Humans
- In Vitro Techniques
- Isoantigens
- Janus Kinase 2 -- immunology
- Mice
- Receptors, Interleukin-6 -- antagonists & inhibitors
- STAT3 Transcription Factor -- immunology
- Signal Transduction -- immunology
- T-Lymphocytes -- immunology
- T-Lymphocytes, Regulatory -- immunology
- Th17 Cells -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.